Cargando…

Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients

The coronavirus disease 2019 (COVID-19) pandemic poses a great threat to public health. Individuals who are immunocompromised because of the progression of the primary disease or receiving immunosuppressive medications are prone to severe COVID-19 complications and poor outcomes. Abundant data have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jin-Wen, Hu, Wei, Shen, Lili, Wang, Fu-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945070/ https://www.ncbi.nlm.nih.gov/pubmed/36719354 http://dx.doi.org/10.1097/CM9.0000000000002505

Ejemplares similares

Immunogenicity of COVID-19 Vaccination in People Living with HIV: Progress and Challenges
por: Song, Jin-Wen, et al.
Publicado: (2023)

Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
por: Mehrabi Nejad, Mohammad-Mehdi, et al.
Publicado: (2022)

Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients
por: Fernández-Prada, María, et al.
Publicado: (2023)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
por: Chilson, Erica, et al.
Publicado: (2020)

Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review
por: Lv, Meng, et al.
Publicado: (2021)

The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
por: Yang, Lei, et al.
Publicado: (2023)

Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity
por: Kim, Enoch, et al.
Publicado: (2022)

COVID-19 vaccines for high risk and immunocompromised patients
por: Pavia, Charles S., et al.
Publicado: (2022)

Vaccination of Immunocompromised Cats
por: Hartmann, Katrin, et al.
Publicado: (2022)

Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China
por: Tian, Qiu-Ju, et al.
Publicado: (2022)

Safety and immunogenicity of synchronous COVID19 and influenza vaccination
por: Baj, Andreina, et al.
Publicado: (2022)

Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination
por: Wagenhäuser, Isabell, et al.
Publicado: (2023)

Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination
por: Saxena, Divyasha, et al.
Publicado: (2023)

Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome
por: Verstappen, Gwenny M, et al.
Publicado: (2022)

Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
por: Tang, Kuo-Tung, et al.
Publicado: (2022)

The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
por: Yang, Lei, et al.
Publicado: (2023)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis
por: Zhao, Tianyu, et al.
Publicado: (2023)

A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines
por: Ashmawy, Rasha, et al.
Publicado: (2022)

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
por: Nurpeisova, Ainur, et al.
Publicado: (2022)

2939. Hepatitis A vaccine immunogenicity in an immunocompromised population: a prospective cohort study
por: Schnyder, Jenny, et al.
Publicado: (2023)

Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
por: Han, Xiaoxu, et al.
Publicado: (2022)

COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
por: He, Qian, et al.
Publicado: (2021)

COVID-19 in immunocompromised children and adolescents
por: Kwak, Byung Ok, et al.
Publicado: (2023)

Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative review
por: Capone, Fioravante, et al.
Publicado: (2022)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
por: LaFleur, Grace E., et al.
Publicado: (2023)

The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
por: Antinori, Andrea, et al.
Publicado: (2023)

Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
por: Widhani, Alvina, et al.
Publicado: (2023)

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
por: Walsh, Edward E., et al.
Publicado: (2020)

Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
por: Kotecha, Rishi S., et al.
Publicado: (2015)

Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study
por: Wang, Xiaoqi, et al.
Publicado: (2022)

Pneumococcal Vaccination in Immunocompromised Hosts: An Update
por: Froneman, Claire, et al.
Publicado: (2021)

Effectiveness and Safety of COVID-19 Vaccination in Patients with Malignant Disease
por: Zhao, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tk885in17u5ckug8hpqapg2k20